i2O Therapeutics
i2O Therapeutics is a startup headquartered in Cambridge, United States, founded in 2019. It has raised at least $3.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
i2O Therapeutics has raised at least $3.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
i2O Therapeutics sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Cambridge
- 2Pi
- Acceleron Fusion
- actnano
- AIScientists
- Apeiron Labs
- Aptamino
- Arches Medical Independents
- Aviceda Therapeutics
- Axoft
- Blitzy
- Caldera Therapeutics
Related
- Innovation profile of Cambridge
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does i2O Therapeutics do?
i2O Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has i2O Therapeutics raised?
At least $3.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is i2O Therapeutics based?
i2O Therapeutics is headquartered in Cambridge, United States.
When was i2O Therapeutics founded?
i2O Therapeutics was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.